Services for Researchers

Clinical Laboratory Diagnostics for Invasive Aspergillosis

About

What services does this resource provide?

• Maintenance of a repository of prospectively collected clinical samples from patients at high risk for and who develop invasive aspergillosis (IA) and from subjects at high risk for IA with potentially interfering medical conditions. The collection will comprise well characterized, sequential samples spanning from pre-symptomatic through to proven IA.
• Evaluation of experimental IA diagnostic tests performed by members of the Aspergillus Technology Consortium (AsTeC) (non-Government link). Members will use samples from animal models of IA, the ASTEC repository, or other clinical sample repositories. Evaluations may include replication studies to determine if the experimental test performs at previously reported levels of specificity, sensitivity, and limit of detection as well as other parameters, comparison studies between Food and Drug Administration (FDA)-cleared tests for IA and experimental IA diagnostic tests, as well as studies to determine what interfering medical conditions affect performance of the investigational assay. Evaluations are performed in GLP-compliant laboratories.

Where are the services provided?

Access

• What are the eligibility criteria?
• What assurances are provided to users?
• What is the application process?
• How are requests prioritized and/or approved?
• What requirements must users fulfill?